Skip to content

A prospective, multi-center, single-group target value clinical investigation to evaluate the efficacy and safety of ThruFly Supportcatheters in the neurovascular interventional procedure

A prospective, multi-center, single-group target value clinical investigation to evaluate the efficacy and safety of ThruFly Supportcatheters in the neurovascular interventional procedure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104200
Enrollment
Unknown
Registered
2025-06-12
Start date
2025-05-22
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients proposed to undergo the neurovascular interventional procedure

Interventions

Test group: Establish a passage to inject or deliver control media, liquids, embolization materials and/or devices to the target blood vessels by the investigational device

Sponsors

Guangzhou Red Cross Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age 18 and 85; 2. Proposed neurovascular interventional surgery; 3. Signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Experiencing surgery or interventional therapy within 1 month; 2. Subarachnoid hemorrhage or intracranial hemorrhage within 2 months; 3. Active ulcer has occurred within 6 months; 4. Preoperative blood pressure> 180 / 100 mmHg or <90 / 60 mmHg; 5. The target aneurysm is blood bubble-like aneurysm, dissecting aneurysm, infectious aneurysm or ruptured aneurysm; 6. The intraoperative microguidewire cannot pass through the target vessel; 7. Pregnant or lactating females; 8. Participating in other clinical investigations; 9. Other operational contraindications (such as severe allergy to anticoagulant / antiplatelet drugs, anesthetic drugs, contrast agents or existing contraindications; acute myocardial infarction, etc.); 10. Not eligible for this investigation as judged by the investigator.

Design outcomes

Primary

MeasureTime frame
Device success rate;

Secondary

MeasureTime frame
Immediate surgical success rate;Incidence of adverse events;Incidence of serious adverse events;Incidence of device defects;

Countries

China

Contacts

Public ContactFan Hongxin

Guangzhou Red Cross Hospital

fhxchina@126.com+86 731 5684 1086

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026